Core Viewpoint - 正品控股有限公司 is seeking to go public in Hong Kong, focusing on the development, sales, and distribution of health and beauty supplements, with a notable market presence but facing challenges in profitability and reliance on a single distribution channel [1][6]. Group 1: Company Overview - 正品控股主要在香港从事保健及美容补充品与产品的开发、销售、营销及分销 [1]. - The company ranks seventh among local suppliers in Hong Kong's health and beauty supplement market, with a market share of approximately 1.6% [1]. - The company has a diverse product portfolio catering to various demographics, focusing on niche markets such as deer-related supplements and pain relief products [2]. Group 2: Financial Performance - The company reported revenues of approximately HKD 43.19 million, HKD 109.62 million, and HKD 130.22 million for the fiscal years 2023, 2024, and 2025, respectively [4]. - Net profit for the same periods was approximately HKD 11.31 million, HKD 35.48 million, and HKD 36.26 million [4]. - The gross profit margin has been declining, recorded at 81.59%, 78.62%, and 75.02% over the three fiscal years [3]. Group 3: Market Position and Challenges - The health and beauty supplement market in Hong Kong is characterized by oligopoly, with the top 10 companies holding a market share of 31.1% [6]. - 正品控股's business model is heavily reliant on the retail channel 万宁, which holds a dominant market share of 34.4% [6][7]. - The company faces challenges in negotiating pricing power due to its dependence on a single distribution channel, which may impact its profitability [7]. Group 4: Industry Growth Outlook - The health and beauty supplement market in Hong Kong is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2029, providing a moderate industry tailwind for 正品控股 [9][11]. - The market size is expected to increase from HKD 2,709 million in 2024 to HKD 3,537.6 million by 2029 [9].